A randomised comparative clinical study to assess the efficacy of Lavangadi Churna over Ajamodadya Churna in the management of Amavata

Background - Amavata is a disease, where involvement of Ama and Vata can be seen. Here formation of Ama and vitiation of Vata take place simultaneously by their respective causative factors. Acharya Madhavakara has described the Amavata first. This Amavata can be compared with Rheumatoid arthritis showing similarities in clinical features. Objective - To assess the effect of Lavangadi churna over Ajamodadya Churna in the management of Amavata. Materials and Methods - The sample size of the study consists of 40 patients of Amavata. and either sex of age group 20-60years. Patients were randomly selected and grouped into 2 groups namely Group A & Group B. Group A were given Lavangadi churna and Group B were given Ajamodadya Churna. The dosage of both the drug is 3gms twice in a day after food with lukewarm water. Follow up was fixed every 15th day i.e., 1st follow up on 15th day, 2nd follow up on 30th day, after treatment follow up on 45th day and duration of treatment was fixed 1 month. Patients were advised to follow Pathyapathya throughout the study. A special proforma was made to record the observation based on subjective and objective parameters. Results and Conclusion - Overall effect of the trial drug showed good response in both subjective parameters & objective parameters and Overall effect of the control drug showed good response in some parameters like Heaviness, Anorexia, Thirst, Fever. Hence trial dug supported research hypothesis. Intervention was cost effective, adaptable, and safe.